Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 327

1.

Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients.

van der Pluijm M, Sutterland AL, van Kuilenburg ABP, Zoetekouw L, de Haan L, Booij J, van de Giessen E.

Ther Adv Psychopharmacol. 2019 Sep 6;9:2045125319872341. doi: 10.1177/2045125319872341. eCollection 2019.

3.

Influence of muscarinic M1 receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study.

Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ.

Psychiatry Res Neuroimaging. 2019 Aug 30;290:5-13. doi: 10.1016/j.pscychresns.2019.06.005. Epub 2019 Jun 23.

PMID:
31252222
4.

Sleep-Cognition Hypothesis In maritime Pilots, what is the effect of long-term work-related poor sleep on cognition and amyloid accumulation in healthy middle-aged maritime pilots: methodology of a case-control study.

Thomas J, Ooms S, Verbeek M, Booij J, Rijpkema M, Kessels RPC, Overeem S, Claassen J.

BMJ Open. 2019 Jun 27;9(6):e026992. doi: 10.1136/bmjopen-2018-026992.

5.

Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome.

van Duin EDA, Vaessen T, Kasanova Z, Viechtbauer W, Reininghaus U, Saalbrink P, Vingerhoets C, Hernaus D, Booij J, Swillen A, Vorstman J, van Amelsvoort T, Myin-Germeys I.

Psychoneuroendocrinology. 2019 Aug;106:85-94. doi: 10.1016/j.psyneuen.2019.03.023. Epub 2019 Mar 22.

PMID:
30959234
6.

Lower [18F]fallypride binding to dopamine D2/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study.

van Duin EDA, Ceccarini J, Booij J, Kasanova Z, Vingerhoets C, van Huijstee J, Heinzel A, Mohammadkhani-Shali S, Winz O, Mottaghy F, Myin-Germeys I, van Amelsvoort T.

Psychol Med. 2019 Apr 2:1-9. doi: 10.1017/S003329171900062X. [Epub ahead of print]

PMID:
30935427
7.

Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study.

Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L.

J Psychopharmacol. 2019 Jun;33(6):660-669. doi: 10.1177/0269881119836229. Epub 2019 Mar 19.

8.

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study.

Joling M, Vriend C, Raijmakers PGHM, van der Zande JJ, Lemstra AW, Berendse HW, Booij J, van den Heuvel OA.

Neuroimage Clin. 2019;22:101755. doi: 10.1016/j.nicl.2019.101755. Epub 2019 Mar 12.

9.

Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone.

Jansen BHE, Kramer GM, Cysouw MCF, Yaqub MM, de Keizer B, Lavalaye J, Booij J, Vargas HA, Morris MJ, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE.

J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10.

PMID:
30630941
10.

Low prevalence of substance use in people with 22q11.2 deletion syndrome.

Vingerhoets C, van Oudenaren MJF, Bloemen OJN, Boot E, van Duin EDA, Evers LJM, Fiksinski AM, Breetvelt EJ, Palmer LD, Vergaelen E, Vogels A, Meijer C, Booij J; Genetic Risk and Outcome of Psychosis (GROUP) investigators, de Haan L, Swillen A, Vorstman JAS, Bassett AS, van Amelsvoort TAMJ.

Br J Psychiatry. 2019 Jan 3:1-7. doi: 10.1192/bjp.2018.258. [Epub ahead of print]

PMID:
30604657
11.

Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis.

Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, Heinzel A, Mottaghy FM, Myin-Germeys I.

Eur Neuropsychopharmacol. 2018 Dec;28(12):1314-1324. doi: 10.1016/j.euroneuro.2018.10.002. Epub 2018 Oct 25.

PMID:
30482598
12.

Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Shalgunov V, van Waarde A, Booij J, Michel MC, Dierckx RAJO, Elsinga PH.

Med Res Rev. 2019 May;39(3):1014-1052. doi: 10.1002/med.21552. Epub 2018 Nov 18. Review.

13.

[123I]Ioflupane imaging in Caucasians and non-Caucasians: Are there any differences?

Ahmed A, Huang J, Chen K, Zubeldia JM, Booij J, Vijayakumar V.

J Neurol Sci. 2018 Dec 15;395:159-163. doi: 10.1016/j.jns.2018.10.001. Epub 2018 Oct 3.

PMID:
30336391
14.

Clinical evaluation of [123I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison.

Adriaanse SM, de Wit TC, Stam M, Verwer E, de Bruin KM, Booij J.

EJNMMI Res. 2018 Aug 22;8(1):85. doi: 10.1186/s13550-018-0436-y.

15.

Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.

Schrantee A, Lucassen PJ, Booij J, Reneman L.

Eur Neuropsychopharmacol. 2018 Oct;28(10):1173-1179. doi: 10.1016/j.euroneuro.2018.07.099. Epub 2018 Aug 4.

PMID:
30082141
16.

Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies.

Joling M, Vriend C, van der Zande JJ, Lemstra AW, van den Heuvel OA, Booij J, Berendse HW.

Neuroimage Clin. 2018 Apr 6;19:130-136. doi: 10.1016/j.nicl.2018.04.009. eCollection 2018.

17.

Striatal dopamine regulates systemic glucose metabolism in humans and mice.

Ter Horst KW, Lammers NM, Trinko R, Opland DM, Figee M, Ackermans MT, Booij J, van den Munckhof P, Schuurman PR, Fliers E, Denys D, DiLeone RJ, la Fleur SE, Serlie MJ.

Sci Transl Med. 2018 May 23;10(442). pii: eaar3752. doi: 10.1126/scitranslmed.aar3752.

PMID:
29794060
18.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 Jun 5;90(23):e2059-e2067. doi: 10.1212/WNL.0000000000005660. Epub 2018 May 11.

19.

Effects of intravenous thyrotropin-releasing hormone on 18F-fluorodeoxyglucose uptake in human brown adipose tissue: a randomized controlled trial.

Heinen CA, Zhang Z, Klieverik LP, de Wit TC, Poel E, Yaqub M, Boelen A, Kalsbeek A, Bisschop PH, van Trotsenburg ASP, Verberne HJ, Booij J, Fliers E.

Eur J Endocrinol. 2018 Jul;179(1):31-38. doi: 10.1530/EJE-17-0966. Epub 2018 May 3.

PMID:
29724865
20.

Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.

van Duin EDA, Kasanova Z, Hernaus D, Ceccarini J, Heinzel A, Mottaghy F, Mohammadkhani-Shali S, Winz O, Frank M, Beck MCH, Booij J, Myin-Germeys I, van Amelsvoort T.

Eur Neuropsychopharmacol. 2018 Jun;28(6):732-742. doi: 10.1016/j.euroneuro.2018.03.005. Epub 2018 Apr 25.

PMID:
29703646
21.

Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis.

Bakker G, Vingerhoets C, Boucherie D, Caan M, Bloemen O, Eersels J, Booij J, van Amelsvoort T.

Neuroimage Clin. 2018 Mar 3;18:713-719. doi: 10.1016/j.nicl.2018.02.030. eCollection 2018.

22.

Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study.

Smit M, Vállez García D, de Jong BM, Zoons E, Booij J, Dierckx RA, Willemsen AT, de Vries EF, Bartels AL, Tijssen MA.

Front Neurol. 2018 Feb 28;9:88. doi: 10.3389/fneur.2018.00088. eCollection 2018.

23.

Performance evaluation of a novel brain-dedicated SPECT system.

Stam MK, Verwer EE, Booij J, Adriaanse SM, de Bruin CM, de Wit TC.

EJNMMI Phys. 2018 Mar 1;5(1):4. doi: 10.1186/s40658-018-0203-1. No abstract available.

24.

Randomised controlled trial of escitalopram for cervical dystonia with dystonic jerks/tremor.

Zoons E, Booij J, Delnooz CCS, Dijk JM, Dreissen YEM, Koelman JHTM, van der Salm SMA, Skorvanek M, Smit M, Aramideh M, Bienfait H, Boon AJW, Brans JWM, Hoogerwaard E, Hovestadt A, Kamphuis DJ, Munts AG, Speelman JD, Tijssen MAJ.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):579-585. doi: 10.1136/jnnp-2017-317352. Epub 2018 Jan 11.

PMID:
29326295
25.

Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorder.

Kasanova Z, Ceccarini J, Frank MJ, van Amelsvoort T, Booij J, van Duin E, Steinhart H, Vaessen T, Heinzel A, Mottaghy F, Myin-Germeys I.

Psychol Med. 2018 Aug;48(11):1909-1914. doi: 10.1017/S0033291717003476. Epub 2017 Dec 13.

PMID:
29233195
26.

Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques.

Hakimzadeh N, Pinas VA, Molenaar G, de Waard V, Lutgens E, van Eck-Smit BLF, de Bruin K, Piek JJ, Eersels JLH, Booij J, Verberne HJ, Windhorst AD.

PLoS One. 2017 Nov 30;12(11):e0187767. doi: 10.1371/journal.pone.0187767. eCollection 2017.

27.

Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.

Vingerhoets C, Bloemen OJN, Boot E, Bakker G, de Koning MB, da Silva Alves F, Booij J, van Amelsvoort TAMJ.

Psychiatry Res Neuroimaging. 2018 Feb 28;272:65-70. doi: 10.1016/j.pscychresns.2017.11.014. Epub 2017 Nov 21.

PMID:
29174435
28.

Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms.

Zoons E, Booij J, Speelman JD, Dreissen YEM, Smit M, Tijssen MAJ.

EJNMMI Res. 2017 Oct 25;7(1):87. doi: 10.1186/s13550-017-0338-4.

29.

The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies.

van Galen KA, Ter Horst KW, Booij J, la Fleur SE, Serlie MJ.

Metabolism. 2018 Aug;85:325-339. doi: 10.1016/j.metabol.2017.09.007. Epub 2017 Sep 29. Review.

PMID:
28970033
30.

Serotonin transporter binding and anxiety symptoms in Parkinson's disease.

Joling M, van den Heuvel OA, Berendse HW, Booij J, Vriend C.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):89-94. doi: 10.1136/jnnp-2017-316193. Epub 2017 Sep 12.

PMID:
28899958
31.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.

Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.

Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.

32.

The effect of the muscarinic M1 receptor antagonist biperiden on cognition in medication free subjects with psychosis.

Vingerhoets C, Bakker G, van Dijk J, Bloemen OJN, Wang Y, Chan RCK, Booij J, van Amelsvoort TAMJ.

Eur Neuropsychopharmacol. 2017 Sep;27(9):854-864. doi: 10.1016/j.euroneuro.2017.06.014. Epub 2017 Jul 6.

PMID:
28689687
33.

Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding.

Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ.

FASEB J. 2017 Oct;31(10):4545-4554. doi: 10.1096/fj.201601234R. Epub 2017 Jul 5.

PMID:
28679529
34.

Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.

Boot E, Hollak CEM, Huijbregts SCJ, Jahja R, van Vliet D, Nederveen AJ, Nieman DH, Bosch AM, Bour LJ, Bakermans AJ, Abeling NGGM, Bassett AS, van Amelsvoort TAMJ, van Spronsen FJ, Booij J.

Psychol Med. 2017 Dec;47(16):2854-2865. doi: 10.1017/S0033291717001398.

PMID:
28552082
35.

Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia.

Booij J, Dubroff J, Pryma D, Yu J, Agarwal R, Lakhani P, Kuo PH.

J Nucl Med. 2017 Nov;58(11):1821-1826. doi: 10.2967/jnumed.116.189266. Epub 2017 May 4.

36.

18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure.

Bahler L, Holleman F, Chan MW, Booij J, Hoekstra JB, Verberne HJ.

PLoS One. 2017 May 2;12(5):e0176242. doi: 10.1371/journal.pone.0176242. eCollection 2017.

37.

Striatal dopaminergic modulation of reinforcement learning predicts reward-oriented behavior in daily life.

Kasanova Z, Ceccarini J, Frank MJ, Amelsvoort TV, Booij J, Heinzel A, Mottaghy F, Myin-Germeys I.

Biol Psychol. 2017 Jul;127:1-9. doi: 10.1016/j.biopsycho.2017.04.014. Epub 2017 Apr 29.

PMID:
28461214
38.

QT prolongation by dexamphetamine: Does experience matter?

Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL.

J Cardiovasc Electrophysiol. 2017 Aug;28(8):912-916. doi: 10.1111/jce.13235. Epub 2017 Jun 21.

PMID:
28452189
39.

The relationship between the dopaminergic system and depressive symptoms in cervical dystonia.

Zoons E, Tijssen MAJ, Dreissen YEM, Speelman JD, Smit M, Booij J.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1375-1382. doi: 10.1007/s00259-017-3664-x. Epub 2017 Mar 17.

40.

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.

Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, Booij J, Lucassen PJ, Reneman L.

PLoS One. 2017 Feb 27;12(2):e0172776. doi: 10.1371/journal.pone.0172776. eCollection 2017.

41.

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.

Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8.

42.

[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods.

Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, Jonsson C, de Nijs R, Hesse S, Koulibaly PM, Akdemir UO, Koole M, Tatsch K, Varrone A.

EJNMMI Phys. 2017 Dec;4(1):8. doi: 10.1186/s40658-017-0175-6. Epub 2017 Jan 28.

43.

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging.

Dickson JC, Tossici-Bolt L, Sera T, Booij J, Ziebell M, Morbelli S, Assenbaum-Nan S, Borght TV, Pagani M, Kapucu OL, Hesse S, Van Laere K, Darcourt J, Varrone A, Tatsch K.

EJNMMI Res. 2017 Dec;7(1):10. doi: 10.1186/s13550-016-0253-0. Epub 2017 Jan 24.

44.

Hot heads & cool bodies: The conundrums of human brown adipose tissue (BAT) activity research.

Bahler L, Holleman F, Booij J, Hoekstra JB, Verberne HJ.

Eur J Intern Med. 2017 May;40:26-29. doi: 10.1016/j.ejim.2016.12.023. Epub 2017 Jan 5. Review.

PMID:
28065662
45.

Biological Mechanisms Whereby Social Exclusion May Contribute to the Etiology of Psychosis: A Narrative Review.

Selten JP, Booij J, Buwalda B, Meyer-Lindenberg A.

Schizophr Bull. 2017 Jan 3. pii: sbw180. doi: 10.1093/schbul/sbw180. [Epub ahead of print]

46.

Advances in Variable Rate Technology Application in Potato in The Netherlands.

Kempenaar C, Been T, Booij J, van Evert F, Michielsen JM, Kocks C.

Potato Res. 2017;60(3):295-305. doi: 10.1007/s11540-018-9357-4. Epub 2018 Feb 19.

47.

Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. doi: 10.1007/s00259-016-3598-8. No abstract available.

PMID:
27987029
48.

The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.

Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357. doi: 10.1007/s00259-016-3589-9. Epub 2016 Dec 6. No abstract available. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):559-560. Saraf LJ [corrected to Jafari L].

PMID:
27924371
49.

Reactivity to social stress in ethnic minority men.

Gevonden M, Myin-Germeys I, Wichers M, Booij J, van den Brink W, van Winkel R, Selten JP.

Psychiatry Res. 2016 Dec 30;246:629-636. doi: 10.1016/j.psychres.2016.10.076. Epub 2016 Nov 2.

PMID:
27884461
50.

Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.

Joling M, Vriend C, van den Heuvel OA, Raijmakers PGHM, Jones PA, Berendse HW, Booij J.

J Nucl Med. 2017 Jul;58(7):1117-1123. doi: 10.2967/jnumed.116.182139. Epub 2016 Nov 17.

Supplemental Content

Support Center